Log in
RegisterFDA: ACPSCP Meeting (HVDs, NTI Drugs) [BE/BA News]
posted by Helmut 
– Vienna, Austria, 2007-03-21 14:56 (6678 d 09:02 ago) – Posting: # 592
Views: 9,382
Dear colleagues,
following topics will be discussed at a public meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (formerly Advisory Committee for Pharmaceutical Science) on 02 May 2007:
following topics will be discussed at a public meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (formerly Advisory Committee for Pharmaceutical Science) on 02 May 2007:
- Receive an update from the Office of Generic Drugs (OGD) on the bioequivalence of highly variable drugs,
- receive an update on and discuss general strategies within the OGD pertaining to the bioequivalence of narrow therapeutic index drug products, and
- discuss and provide comments on the topic of alcohol-induced dose dumping.
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
Helmut Schütz
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- FDA: ACPSCP Meeting (HVDs, NTI Drugs)Helmut 2007-03-21 13:56
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- FDA: ACPSCP Meeting (HVDs, NTI Drugs) Ohlbe 2007-04-06 16:38
- FDA: ACPSCP Meeting cancelled Helmut 2007-04-06 16:49
- FDA: ACPSCP Meeting (HVDs, NTI Drugs) Ohlbe 2007-04-06 16:38
Ing. Helmut Schütz